iBio (IBIO) Gains from Investment Securities (2020 - 2023)
iBio's (IBIO) quarterly Gains from Investment Securities came in at $113000.0 in Q1 2023, up 9.71% year-on-year from $103000.0 in Q1 2022, and up 213.89% on a QoQ basis from $36000.0 in Q4 2022.
iBio (IBIO) Gains from Investment Securities (2020 - 2023) Analysis & Trends
iBio (IBIO) has 4 years of Gains from Investment Securities data on file, last reported at $113000.0 in Q1 2023.
- On a quarterly basis, Gains from Investment Securities rose 9.71% year-over-year to $113000.0 in Q1 2023; TTM through Sep 2023 was $149000.0, a 6.29% decrease from a year earlier, with the FY2023 full-year figure at $159000.0, up 6.0% from the prior year.
- Gains from Investment Securities for Q1 2023 stood at $113000.0, up from $36000.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for IBIO reached as high as $113000.0 in Q1 2023 and fell as low as -$7000.0 in Q2 2021.
- Historically, Gains from Investment Securities has averaged $33800.0 across 4 years, with a median of $19500.0 in 2020.
- Across the five-year window, Gains from Investment Securities surged 900.0% in 2022 and rose 9.71% in 2023, its largest moves.
- Year by year, Gains from Investment Securities stood at $20000.0 in 2020, then soared by 35.0% to $27000.0 in 2021, then soared by 33.33% to $36000.0 in 2022, then soared by 213.89% to $113000.0 in 2023.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were $113000.0 in Q1 2023, $36000.0 in Q4 2022, and $10000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 113,000.00 |
| Mar 31, 2023 | 113,000.00 |
| Dec 31, 2022 | 36,000.00 |
| Dec 31, 2022 | 36,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 103,000.00 |
| Mar 31, 2022 | 103,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | -7,000.00 |
| Jun 30, 2021 | -7,000.00 |
| Mar 31, 2021 | 16,000.00 |
| Mar 31, 2021 | 16,000.00 |
| Dec 31, 2020 | 20,000.00 |
| Dec 31, 2020 | 20,000.00 |